Novo Nordisk (NVO) has released an update.
Novo Nordisk has announced a significant transaction under its 2024 share repurchase program, acquiring 6.31 million B shares from Novo Holdings for DKK 4.74 billion. This move is part of a larger strategy to repurchase up to DKK 20 billion in shares over a year. Novo Holdings maintains a substantial voting power at 77.3%, even as its ownership slightly decreased to 28.1% of Novo Nordisk’s share capital.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
